National Institutes of Health: Myositis trials
The registry lists 14 Myositis studies with National Institutes of Health as lead sponsor. 3 are open to participants now and 2 have results posted.
Phase 1 1Phase 2 5Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Ublituximab in Autoantibody Positive Immune Mediated Necrotizing MyopathyRecruitingNCT07103746Phase 2
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruitingNCT01276470
- Adult and Juvenile MyositisRecruitingNCT00017914
- Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal ConditionsTerminatedNCT03912428Phase 1Results posted
- Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisCompletedNCT03267277Phase 2/3Results posted
- Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWithdrawnNCT07012057Phase 2
- Environmental Risk Factors for Myositis in Military PersonnelCompletedNCT01734369
- Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue DiseasesCompletedNCT00341679
- Alemtuzumab to Treat Sporadic Inclusion Body MyositisCompletedNCT00079768Phase 2
- Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile DermatomyositisCompletedNCT00059748
- Study of Families With Twins or Siblings Discordant for Rheumatic DisordersCompletedNCT00055055
- Immune Abnormalities in Sporadic Inclusion Body MyositisCompletedNCT00030212
- Genetic and Family Studies of Inherited Muscle DiseasesCompletedNCT00001331
- Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory MyopathiesCompletedNCT00001261Phase 2